{
    "2021-05-28": [
        [
            {
                "time": "",
                "original_text": "开源证券：康泰生物（300601.SZ）厚积薄发，逐浪疫苗新蓝海，首予“买入”评级",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "疫苗",
                        "新蓝海",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "开源证券首予康泰生物买入评级，公司首次覆盖报告：厚积薄发，逐浪疫苗新蓝海",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "买入评级",
                        "首次覆盖",
                        "疫苗",
                        "新蓝海"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}